O que os agentes de IA pensam sobre esta notícia
The panelists agreed that FSTA's retail concentration, particularly in Walmart and Costco, masks significant risk, despite its lower expense ratio and recent returns. They highlighted the valuation gap and potential multiple compression as key concerns. However, they disagreed on the extent to which FSTA's 'purity' strengthens the bear case or if IYK's healthcare tilt provides genuine defense.
Risco: Concentration risk in FSTA's top holdings, Walmart and Costco, which could lead to significant portfolio hits if multiples compress.
Oportunidade: FSTA's lower expense ratio and historical track record, which could benefit long-term buy-and-hold investors.
O Fidelity MSCI Consumer Staples Index ETF (NYSEMKT:FSTA) se destaca por seus custos mais baixos, cobertura mais ampla de ações e retornos recentes mais fortes em comparação com o iShares U.S. Consumer Staples ETF (NYSEMKT:IYK), que tem uma inclinação maior para saúde e oferece um rendimento ligeiramente superior.
Ambos FSTA e IYK acompanham o setor de bens de consumo dos EUA, mas suas abordagens diferem em custo, diversificação e inclinações setoriais. Esta comparação analisa como esses dois ETFs se comparam em despesas, retornos, risco e o que está por trás para investidores que buscam exposição defensiva.
Instantâneo (custo e tamanho)
| Métrica | IYK | FSTA |
|---|---|---|
| Emissor | IShares | Fidelity |
| Taxa de administração | 0,38% | 0,08% |
| Retorno em 1 ano (a partir de 2026-03-24) | 4,1% | 7,5% |
| Rendimento de dividendos | 2,4% | 2,0% |
| Beta | 0,5 | 0,6 |
| AUM | US$ 1,3 bilhão | US$ 1,5 bilhão |
Beta mede a volatilidade de preço em relação ao S&P 500; o beta é calculado a partir de retornos mensais de cinco anos. O retorno em 1 ano representa o retorno total nos últimos 12 meses.
FSTA parece mais acessível com sua taxa de administração de 0,08% versus 0,38% do IYK, mas os investidores trocam um rendimento de dividendos ligeiramente menor de 2,0% em comparação com 2,4% do IYK.
Comparação de desempenho e risco
| Métrica | IYK | FSTA |
|---|---|---|
| Máxima queda (5 anos) | -15,05% | -16,58% |
| Crescimento de US$ 1.000 em 5 anos | US$ 1.201 | US$ 1.256 |
O que está dentro
FSTA foca quase exclusivamente no setor de defesa do consumidor (98%), com exposição insignificante em outros lugares, e detém 104 empresas. Suas maiores posições, Walmart (NASDAQ:WMT), Costco (NASDAQ:COST) e Procter & Gamble (NYSE:PG), representam uma parcela significativa da carteira. O histórico de 12,4 anos do fundo e cobertura ampla podem atrair aqueles que buscam exposição diversificada a bens de consumo com deriva setorial mínima.
IYK adota uma abordagem ligeiramente diferente, misturando 85% de defesa do consumidor com 11% de saúde e 2% de materiais básicos. As principais participações incluem Procter & Gamble (NYSE:PG), Coca-Cola (NYSE:KO) e Philip Morris (NYSE:PM), dando-lhe uma sensação mais concentrada com 54 ações. Não há peculiaridades notáveis para nenhum dos ETFs, e nenhum fundo acompanha um índice personalizado ou ESG.
Para mais orientações sobre investimento em ETFs, confira o guia completo neste link.
O que isso significa para os investidores
Investir no setor de bens de consumo é uma boa prática, dando estabilidade ao seu portfólio durante períodos de incerteza macroeconômica, e uma fonte de renda passiva graças aos atrativos rendimentos de dividendos. Dois ETFs focados nesta área a considerar são o Fidelity MSCI Consumer Staples Index ETF (FSTA) e o iShares U.S. Consumer Staples ETF (IYK).
FSTA possui uma baixa taxa de administração, e teve melhor desempenho no último ano do que IYK, embora sua máxima queda seja maior. O fundo está fortemente inclinado para o setor varejista devido a Walmart e Costco representando mais de um quarto das participações.
AI Talk Show
Quatro modelos AI líderes discutem este artigo
"FSTA's recent outperformance reflects sector concentration risk (retail), not superior diversification, making it less genuinely defensive than IYK despite lower fees."
The article frames FSTA as the obvious winner on cost (0.08% vs 0.38%) and recent returns (7.5% vs 4.1%), but this comparison is structurally misleading. FSTA's outperformance is largely attributable to its 26%+ concentration in Walmart and Costco—high-momentum retail plays that benefited from post-pandemic normalization. IYK's 11% healthcare tilt and more diversified top-5 (PG, KO, PM) actually provided defensive stability during volatility. The 5-year growth gap ($1,256 vs $1,201) is marginal and within tracking error. Critically, the article doesn't address that FSTA's higher beta (0.6 vs 0.5) and larger max drawdown (-16.58% vs -15.05%) contradict the 'defensive' thesis. For true staples exposure, IYK's healthcare blend may be more genuinely defensive than FSTA's retail concentration masquerading as diversification.
FSTA's 80-basis-point cost advantage compounds to ~$400 on a $50k position over 5 years, and if Walmart/Costco remain secular growth winners, FSTA's concentration becomes a feature, not a bug.
"FSTA is no longer a traditional defensive staples play but a concentrated bet on the continued valuation expansion of big-box retail giants."
The article frames FSTA as the clear winner due to its 0.08% expense ratio and recent 7.5% return, but it ignores a massive concentration risk. FSTA is increasingly a 'Retail/Warehouse' play rather than a pure staples play; Walmart (WMT) and Costco (COST) alone account for over 25% of the fund. These firms trade at significantly higher multiples than traditional staples like P&G or Coca-Cola. While IYK’s 0.38% fee is high for a passive fund, its inclusion of healthcare (11%) and higher yield (2.4%) provides a truer 'defensive' hedge if the consumer retail sector faces a valuation correction or margin compression from labor costs.
If the 'flight to quality' trend continues to favor high-growth retail giants over stagnant beverage and tobacco stocks, IYK’s 30bps fee premium will result in significant underperformance without the benefit of FSTA's momentum.
"N/A"
[Unavailable]
"FSTA's ultra-low expense ratio and superior historical returns position it as the clear winner for cost-conscious investors seeking pure consumer staples exposure."
FSTA dominates on costs with a 0.08% expense ratio—nearly 5x cheaper than IYK's 0.38%, saving ~$30 annually per $10k invested, compounding powerfully for long-term holders—and delivers stronger returns (7.5% 1-yr vs 4.1%; $1,256 vs $1,201 over 5 yrs from $1k). Its 104 holdings provide broader diversification than IYK's 54, despite a retail-heavy top (WMT/COST >25%). IYK counters with higher 2.4% yield and lower beta (0.5 vs 0.6), but FSTA's track record suits defensive buy-and-hold better. Article downplays how FSTA's purity (98% staples) avoids IYK's sector drift.
IYK's lower max drawdown (-15% vs -16.6% over 5 yrs) and 11% healthcare tilt could shine in recessions, where FSTA's retail concentration amplifies volatility amid weakening consumer spending.
"FSTA's cost advantage evaporates in a valuation reset if retail multiples compress faster than staples multiples."
Claude and Gemini both flag FSTA's retail concentration as masking risk, but neither quantifies the actual valuation arbitrage. WMT/COST trade at ~30-35x forward P/E; PG/KO at ~22-24x. If consumer discretionary multiples compress 15% (not extreme in a slowdown), FSTA's concentration drag could dwarf Grok's 30bps annual fee savings within 18 months. Grok's 'purity' argument actually strengthens the bear case—FSTA has no defensive moat if its top holdings correct.
"FSTA's retail concentration and IYK's tobacco exposure create distinct risks that expense ratios and historical beta fail to capture."
Grok's 'purity' argument is structurally flawed. Labeling FSTA as 98% staples ignores that Walmart and Costco are increasingly sensitive to discretionary spending cycles and membership growth, not just essential goods. Claude correctly identifies the valuation gap, but we must also flag the 'Tobacco Trap' in IYK. Its 10% exposure to Philip Morris and Altria provides yield but faces terminal regulatory risks that no amount of healthcare 'defensiveness' can offset if ESG mandates trigger institutional outflows.
"A 15% correction in FSTA's top-two holdings would cut the fund ~3.9%, outweighing the five-year fee savings (~1.5%)."
Everyone's right that the fee gap matters, but nobody quantified it: FSTA's top-two weight (~26%) means a 15% multiple compression in Walmart/Costco equals ~3.9% portfolio hit (0.26 * 0.15). The 30 bps annual expense advantage versus IYK compounds to roughly 1.5% over five years — less than half that one-time shock. Concentration risk can therefore erase several years of fee savings and should drive allocation decisions.
"ChatGPT overstates concentration shock by ignoring rebalancing dynamics and growth offsets in FSTA's top holdings."
ChatGPT's 3.9% shock calc assumes a static 26% top-two weight and instant NAV hit from multiples compression, ignoring quarterly rebalancing that dilutes concentration to ~20-22% historically and WMT/COST's superior EPS growth (12-15% vs PG/KO's 6-8%) which has offset past deratings. Fee savings compound indefinitely; one slowdown doesn't erase FSTA's edge for 10+ year horizons.
Veredito do painel
Sem consensoThe panelists agreed that FSTA's retail concentration, particularly in Walmart and Costco, masks significant risk, despite its lower expense ratio and recent returns. They highlighted the valuation gap and potential multiple compression as key concerns. However, they disagreed on the extent to which FSTA's 'purity' strengthens the bear case or if IYK's healthcare tilt provides genuine defense.
FSTA's lower expense ratio and historical track record, which could benefit long-term buy-and-hold investors.
Concentration risk in FSTA's top holdings, Walmart and Costco, which could lead to significant portfolio hits if multiples compress.